Literature DB >> 2674199

Unsatisfactory specificities and sensitivities of six enzyme immunoassays for antibodies to hepatitis B core antigen.

G Caspari1, H J Beyer, G Elbert, K Koerner, P Muss, F W Schunter, A Uy, W Gerlich, R Thomssen, H Schmitt.   

Abstract

To examine the consistency and comparability of anti-hepatitis B core antigen (anti-HBcAg) assays, four blood donation centers of the Red Cross in the Federal Republic of Germany tested 4,080 unselected blood donors with six different tests in parallel. Confirmation testing of reactive samples was done in the National Reference Center for Viral Hepatitis. Depending on the test kit used, 4.1 to 9.9% of serum samples were initially positive and 2.9 to 7.5% were repeatedly positive. Sixteen percent of serum samples were positive in at least one test but only three percent were positive in all six tests. Statistical analysis of frequency distribution of optical densities for each test suggested that there should be a correction of the cutoff values. This reduced the number of false-positive results by half, but a significant proportion of discrepant results could not be resolved. The lack of specificity and consistency requires cautious interpretation of isolated anti-HBcAg results in clinical specimens. Screening of predominantly anti-HBcAg-negative populations (e.g., blood donors) by the current anti-HBcAg test kits will almost necessarily give unsatisfactory results.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2674199      PMCID: PMC267740          DOI: 10.1128/jcm.27.9.2067-2072.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  A review of recent events related to surrogate testing of blood to prevent non-A, non-B posttransfusion hepatitis.

Authors:  T F Zuck; W C Sherwood; J R Bove
Journal:  Transfusion       Date:  1987 Mar-Apr       Impact factor: 3.157

2.  Current tests for antibody to hepatitis b core antigen used to screen donors for non-A, non-B hepatitis are comparable to the original radioimmunoassay for hepatitis B core antigen.

Authors:  C L Troisi; F B Hollinger
Journal:  Transfusion       Date:  1987 Sep-Oct       Impact factor: 3.157

3.  Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood.

Authors:  D E Koziol; P V Holland; D W Alling; J C Melpolder; R E Solomon; R H Purcell; L M Hudson; F J Shoup; H Krakauer; H J Alter
Journal:  Ann Intern Med       Date:  1986-04       Impact factor: 25.391

4.  Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study.

Authors:  C E Stevens; R D Aach; F B Hollinger; J W Mosley; W Szmuness; R Kahn; J Werch; V Edwards
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

5.  The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen.

Authors:  D R Milich; A McLachlan
Journal:  Science       Date:  1986-12-12       Impact factor: 47.728

6.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

  6 in total
  8 in total

1.  Improvement in the specificity of assays for detection of antibody to hepatitis B core antigen.

Authors:  J A Weare; E F Robertson; G Madsen; R Hu; R H Decker
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  Improvements in detection of antibody to hepatitis B core antigen by treating specimens with reducing agent in an automated microparticle enzyme immunoassay.

Authors:  A M Spronk; L Schmidt; C Krenc; L Pavlis-Jenkins; J Brady; S Taskar; L Angus-Finn; L Mimms
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

3.  Characterization of a reduction-sensitive factor from human plasma responsible for apparent false activity in competitive assays for antibody to hepatitis B core antigen.

Authors:  E F Robertson; J A Weare; R Randell; P V Holland; G Madsen; R H Decker
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

4.  Prevalence of antibodies to recombinant hepatitis C virus protein C100-3 and of elevated transaminase levels in blood donors from Northern Germany.

Authors:  G Caspari; J Beyer; K Richter; W H Gerlich; H Schmitt
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

5.  Is screening of blood donors for anti-HBc useful?

Authors:  G Caspari; H J Beyer; H Schmitt; W Gerlich; A Uy; R Thomssen
Journal:  Blut       Date:  1990-06

6.  Novel double-antigen sandwich immunoassay for human hepatitis B core antibody.

Authors:  An Li; Quan Yuan; Zhiyin Huang; Jian Fan; Ruyi Guo; Bin Lou; Qin Zheng; Shengxiang Ge; Yixin Chen; Zhijun Su; Anthony E T Yeo; Yu Chen; Jun Zhang; Ningshao Xia
Journal:  Clin Vaccine Immunol       Date:  2010-01-27

7.  Investigating the presence of HIV sequences and the distribution of virological markers in hemophiliacs and their sexual partners.

Authors:  M da S Cardoso; S Epple; K Koerner; B Kubanek; D Ellbrück; E Seifried
Journal:  Ann Hematol       Date:  1991-12       Impact factor: 3.673

8.  Expression of the core antigen gene of hepatitis B virus (HBV) in Acetobacter methanolicus using broad-host-range vectors.

Authors:  R Schröder; A Maassen; A Lippoldt; T Börner; R von Baehr; P Dobrowolski
Journal:  Appl Microbiol Biotechnol       Date:  1991-08       Impact factor: 4.813

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.